RU2003106395A - Водные фармацевтические композиции - Google Patents
Водные фармацевтические композиции Download PDFInfo
- Publication number
- RU2003106395A RU2003106395A RU2003106395/15A RU2003106395A RU2003106395A RU 2003106395 A RU2003106395 A RU 2003106395A RU 2003106395/15 A RU2003106395/15 A RU 2003106395/15A RU 2003106395 A RU2003106395 A RU 2003106395A RU 2003106395 A RU2003106395 A RU 2003106395A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- viscosity
- mpa
- vol
- aqueous solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (5)
1. Антибактериальная водная фармацевтическая композиция, которая включает в себя 2,8-4 мас./об.% метилцеллюлозы, 2 мас./об.% водный раствор которой имеет вязкость 12 мПа·с или ниже при 20°С, 1,5-2,3 мас./об.% лимонной кислоты, 2-4 мас./об.% полиэтиленгликоля и 0,1-0,5 мас./об.% офлоксацина.
2. Антибактериальная водная фармацевтическая композиция, которая включает в себя 2,8-4 мас./об.% метилцеллюлозы, 2 мас./об.% водный раствор которой имеет вязкость 12 мПа·с или ниже при 20°С, 1,5-2,3 мас./об.% лимонной кислоты, 2-4 мас./об.% полиэтиленгликоля и 0,1-0,5 мас./об.% по меньшей мере одного из новых хинолоновых антибактериальных средств, выбранных из группы, состоящей из офлоксацина, левофлоксацина и моксифлоксацина гидрохлорида.
3. Водная фармацевтическая композиция, которая включает в себя 2,3-8 мас./об.% метилцеллюлозы, 2 мас./об.% водный раствор которой имеет вязкость 12 мПа·с или ниже при 20°С, 0,14-4 мас./об.% по меньшей мере одной из кислот, выбранных из группы, состоящей из поливалентной карбоновой кислоты, молочной кислоты и глюконовой кислоты, и эффективного количества фармацевтического средства.
4. Водная фармацевтическая композиция, которая включает в себя 2,3-8 мас./об.% метилцеллюлозы, 2 мас./об.% водный раствор которой имеет вязкость 12 мПа·с или ниже при 20°С, 0,5-13 мас./об.% полиэтиленгликоля и эффективное количество фармацевтического средства.
5. Водная фармацевтическая композиция, которая включает в себя 2,3-8 мас./об.% метилцеллюлозы, 2 мас./об.% водный раствор которой имеет вязкость 12 мПа·с или ниже при 20°С, 0,14-4 мас./об.% по меньшей мере одной из кислот, выбранных из группы, состоящей из поливалентной карбоновой кислоты, молочной кислоты и глюконовой кислоты, 0,5-13 мас./об.% полиэтиленгликоля и эффективное количество фармацевтического средства.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000240455A JP3450805B2 (ja) | 2000-08-08 | 2000-08-08 | 水性医薬組成物 |
JP2000-240455 | 2000-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2003106395A true RU2003106395A (ru) | 2004-07-27 |
Family
ID=18731808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003106395/15A RU2003106395A (ru) | 2000-08-08 | 2001-08-08 | Водные фармацевтические композиции |
Country Status (13)
Country | Link |
---|---|
US (2) | US20030194441A1 (ru) |
EP (1) | EP1312366B1 (ru) |
JP (1) | JP3450805B2 (ru) |
KR (1) | KR20030040384A (ru) |
CN (1) | CN1446092A (ru) |
AT (1) | ATE376423T1 (ru) |
AU (1) | AU2001278696A1 (ru) |
CA (1) | CA2421787A1 (ru) |
DE (1) | DE60131088T2 (ru) |
HU (1) | HUP0302690A3 (ru) |
NO (1) | NO20030533L (ru) |
RU (1) | RU2003106395A (ru) |
WO (1) | WO2002011734A1 (ru) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003264498A1 (en) * | 2002-09-18 | 2004-04-08 | Wakamoto Pharmaceutical Co., Ltd. | Transparent and reversibly heat-gelling aqueous compositions |
US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
US20050085446A1 (en) * | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
JP2005008625A (ja) * | 2003-05-23 | 2005-01-13 | Santen Pharmaceut Co Ltd | キノロン系抗菌化合物を含有する点眼液 |
JP5222462B2 (ja) * | 2003-08-21 | 2013-06-26 | スキャンポ・アーゲー | 眼科用組成物 |
KR101144647B1 (ko) * | 2003-10-31 | 2012-05-08 | 와카모토 세이야꾸 가부시끼가이샤 | 가역성 열 겔화 수성 조성물 |
JP2005263792A (ja) * | 2004-02-19 | 2005-09-29 | Santen Pharmaceut Co Ltd | 澄明なラタノプロスト点眼液 |
WO2005079809A1 (ja) * | 2004-02-19 | 2005-09-01 | Santen Pharmaceutical Co., Ltd. | 澄明なラタノプロスト点眼液 |
US7658947B2 (en) * | 2004-06-25 | 2010-02-09 | Kimberly-Clark Worldwide, Inc. | Thermo-gelling composition |
JP2007277095A (ja) * | 2004-07-02 | 2007-10-25 | Wakamoto Pharmaceut Co Ltd | アジスロマイシン含有可逆性熱ゲル化水性組成物 |
JP2006036660A (ja) * | 2004-07-23 | 2006-02-09 | Wakamoto Pharmaceut Co Ltd | 難溶性薬物含有水性懸濁熱ゲル製剤 |
US20060089384A1 (en) * | 2004-10-25 | 2006-04-27 | Minno George E | Ophthalmic compositions and methods of using the same |
KR101252310B1 (ko) * | 2004-10-25 | 2013-04-08 | 보오슈 앤드 롬 인코포레이팃드 | 안과용 조성물 및 이의 사용 방법 |
US20080014274A1 (en) * | 2006-07-14 | 2008-01-17 | Wyeth | Enhanced stability phenylephrine liquid compositions |
CN101130083B (zh) * | 2007-08-07 | 2010-05-19 | 山东博士伦福瑞达制药有限公司 | 一种眼用组合物及其制作方法和用途 |
ITMI20080289A1 (it) * | 2008-02-22 | 2009-08-23 | S I F I Societa Industria Farmaceutica Italia | Composizioni di gemifloxacina con elevata efficacia su patologie oculari |
EP2143422A1 (en) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
US7842725B2 (en) | 2008-07-24 | 2010-11-30 | Ecolab USA, Inc. | Foaming alcohol compositions with selected dimethicone surfactants |
TW201023912A (en) * | 2008-12-05 | 2010-07-01 | Alcon Res Ltd | Pharmaceutical suspension |
EP2403342A4 (en) * | 2009-03-03 | 2013-06-05 | Alcon Res Ltd | PHARMACEUTICAL COMPOSITION FOR IL-ADMINISTRATION OF TYROSINE KINASE RECEPTOR INHIBITING COMPOUNDS (RTKI) |
WO2010101989A1 (en) * | 2009-03-03 | 2010-09-10 | Alcon Research, Ltd. | PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
CN102791270A (zh) * | 2010-01-07 | 2012-11-21 | 明尼苏达大学董事会 | 将莫西沙星应用于耳的方法和组合物 |
CN101843625B (zh) * | 2010-03-30 | 2012-02-08 | 重庆巴仕迪动物药业有限公司 | 兽用复方氧氟沙星注射液及其制备方法 |
US20120022149A1 (en) * | 2010-07-21 | 2012-01-26 | Chowhan Masood A | Pharmaceutical composition with enhanced solubility characteristics |
US9937258B2 (en) * | 2013-07-17 | 2018-04-10 | Dow Global Technologies Llc | Composition for application to a nasal mucosa comprising a methylcellulose |
CN104000777B (zh) * | 2014-05-21 | 2016-06-01 | 丽珠医药集团股份有限公司 | 一种左氧氟沙星制剂 |
CN104784101A (zh) * | 2015-03-05 | 2015-07-22 | 中国药科大学制药有限公司 | 一种曲尼司特凝胶和软膏剂的处方及制备方法 |
CN110913867B (zh) * | 2017-04-25 | 2021-06-11 | 若素制药株式会社 | 热凝胶化人工泪液 |
US20180318319A1 (en) | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
CN109260152A (zh) * | 2018-11-13 | 2019-01-25 | 禹州市中医院 | 一种盐酸洛美沙星滴耳液 |
US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
HUE057416T2 (hu) * | 2019-07-23 | 2022-05-28 | Nicox Ophthalmics Inc | Eljárás flutikazon-propionát A forma nanokristályok szemészeti steril vizes szuszpenzióinak elõállítására |
CN117338787A (zh) * | 2023-11-24 | 2024-01-05 | 南京恒道医药科技股份有限公司 | 一种眼用药物组合物及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE84968T1 (de) * | 1987-11-13 | 1993-02-15 | Asta Medica Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
ES2141775T3 (es) * | 1993-04-16 | 2000-04-01 | Wakamoto Pharma Co Ltd | Composicion medicinal a base de agua termicamente gelificante reversible. |
US5756552A (en) * | 1994-10-13 | 1998-05-26 | Wakamoto Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation |
JP3672569B2 (ja) * | 1995-01-20 | 2005-07-20 | わかもと製薬株式会社 | 抗炎症点眼剤 |
ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
WO1998030221A1 (fr) * | 1997-01-10 | 1998-07-16 | Wakamoto Pharmaceutical Co., Ltd. | Composition de type emulsion huile/eau a usage ophtalmique et contenant du difluprednate |
EP1020194A4 (en) * | 1997-10-01 | 2003-05-21 | Wakamoto Pharma Co Ltd | OIL / WATER EMULSION COMPILATIONS |
US6171616B1 (en) * | 1998-04-13 | 2001-01-09 | Shin-Etsu Chemical Co., Ltd. | Solid preparation and a method of manufacturing it |
EP1082966A4 (en) * | 1998-05-15 | 2004-07-21 | Wakamoto Pharma Co Ltd | ANTI-INFLAMMATORY EYE DROPS |
AU4061599A (en) * | 1998-06-10 | 1999-12-30 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous preparations containing hardly soluble drug |
JP2001048807A (ja) * | 1999-08-04 | 2001-02-20 | Wakamoto Pharmaceut Co Ltd | 難溶性薬物を水に溶解してなる製剤 |
AU1548001A (en) * | 1999-11-24 | 2001-06-04 | Wakamoto Pharmaceutical Co., Ltd. | Ophthalmic aqueous preparation |
JP4541504B2 (ja) * | 2000-06-14 | 2010-09-08 | 沢井製薬株式会社 | トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤 |
JP2002097129A (ja) * | 2000-07-21 | 2002-04-02 | Rohto Pharmaceut Co Ltd | 点眼剤 |
-
2000
- 2000-08-08 JP JP2000240455A patent/JP3450805B2/ja not_active Expired - Lifetime
-
2001
- 2001-08-08 KR KR10-2003-7001677A patent/KR20030040384A/ko not_active Application Discontinuation
- 2001-08-08 RU RU2003106395/15A patent/RU2003106395A/ru not_active Application Discontinuation
- 2001-08-08 WO PCT/JP2001/006805 patent/WO2002011734A1/ja active IP Right Grant
- 2001-08-08 CA CA002421787A patent/CA2421787A1/en not_active Abandoned
- 2001-08-08 EP EP01956809A patent/EP1312366B1/en not_active Expired - Lifetime
- 2001-08-08 AU AU2001278696A patent/AU2001278696A1/en not_active Abandoned
- 2001-08-08 HU HU0302690A patent/HUP0302690A3/hu unknown
- 2001-08-08 CN CN01813880A patent/CN1446092A/zh active Pending
- 2001-08-08 DE DE60131088T patent/DE60131088T2/de not_active Expired - Lifetime
- 2001-08-08 AT AT01956809T patent/ATE376423T1/de not_active IP Right Cessation
- 2001-08-08 US US10/344,189 patent/US20030194441A1/en not_active Abandoned
-
2003
- 2003-02-03 NO NO20030533A patent/NO20030533L/no not_active Application Discontinuation
-
2006
- 2006-03-13 US US11/374,450 patent/US7612115B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7612115B2 (en) | 2009-11-03 |
JP3450805B2 (ja) | 2003-09-29 |
ATE376423T1 (de) | 2007-11-15 |
EP1312366B1 (en) | 2007-10-24 |
JP2003160473A (ja) | 2003-06-03 |
CA2421787A1 (en) | 2003-02-04 |
NO20030533L (no) | 2003-02-26 |
DE60131088D1 (de) | 2007-12-06 |
DE60131088T2 (de) | 2008-07-31 |
EP1312366A4 (en) | 2006-04-26 |
EP1312366A1 (en) | 2003-05-21 |
HUP0302690A2 (hu) | 2003-11-28 |
HUP0302690A3 (en) | 2004-06-28 |
NO20030533D0 (no) | 2003-02-03 |
AU2001278696A1 (en) | 2002-02-18 |
US20030194441A1 (en) | 2003-10-16 |
EP1312366A8 (en) | 2003-11-12 |
CN1446092A (zh) | 2003-10-01 |
KR20030040384A (ko) | 2003-05-22 |
US20060172969A1 (en) | 2006-08-03 |
WO2002011734A1 (fr) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003106395A (ru) | Водные фармацевтические композиции | |
EA200300449A1 (ru) | Аза- и полиаза-нафталинилкарбоксамиды, полезные в качестве ингибиторов вич-интегразы | |
SI9420031B (sl) | Risperidonski pamoat | |
HK1084582A1 (en) | Stable solid medicinal composition for oral administration | |
DE60040979D1 (de) | (s)-benzochinolizincarbonsäuren und ihre verwendung als antibakterielle mittel | |
HRP20120634T1 (hr) | Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi, te njihova uporaba | |
ATE318266T1 (de) | 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten | |
ES2297067T3 (es) | Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados. | |
PE20232046A1 (es) | N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas | |
EP2136812B1 (en) | Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria | |
PT85808B (pt) | Processo de preparacao de uma solucao aquosa contendo uma quinolona do acido carboxilico | |
CA2676082C (en) | Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract | |
RU2004131858A (ru) | Согревающие и нераздражающие безводные смазывающие композиции | |
RU97107154A (ru) | Водные композиции, содержащие ципрофлоксацин, их применение и способ получения | |
JPWO2007074904A1 (ja) | 水性医薬組成物 | |
ATE265230T1 (de) | Lösliche zusammensetzungen von toremifene | |
WO1998019707A1 (en) | Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions | |
JPH0782141A (ja) | 動物用注射剤 | |
RU2018130991A (ru) | Дезинфицирующий агент | |
TH62857A (th) | อนุพันธ์กรดคาร์บอกซิลิกสำหรับใช้เป็น ip แอนทาโกนิสต์ | |
TH57759B (th) | ยาเม็ดที่มีการปลดปล่อยในทันที | |
JP2009013082A (ja) | シラミ用シャンプーの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20050111 |